Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Mohammed Zayed

Dr Mohammed Zayed

Mohammed Zayed


Clinical Research Fellow

In 2020, Mohammed joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) at the University of Oxford as a Clinical Research Fellow working on large randomised clinical trials.

These include: ORION-4 (a cardiovascular outcome trial of the cholesterol-lowering drug; inclisiran); LENS (a major streamlined study which is investigating the effect of the cholesterol-lowering drug, fenofibrate, on the progression of diabetic eye disease); and, RECOVERY (an international clinical trial aims to identify treatments that may be beneficial for people hospitalised with suspected or confirmed COVID-19) . He is also a part-time GP and a GMC PLAB examiner. 

Mohammed graduated from Alexandria Medical School in Egypt in 2010 where he was awarded his MBChB degree with Honours. He then moved to the UK and completed his foundation training in 2012. He gained experience working in Ophthalmology and as a medical tutor in the Royal Hallamshire Hospital and the University of Sheffield between 2012 and 2014. He completed his GP training and obtained his MRCGP in Leeds in 2017 and was awarded the title of Visiting Lecturer at the University of Leeds. 

He joined Swansea University Medical School in 2018 as an Academic GP and was awarded his MSc degree in Clinical Medicine with Distinction in 2021. 

Recent publications

More publications